REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 3rd, 2014 • Forest Laboratories Inc • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Purchase Agreement dated as of January 27, 2014 (the “Purchase Agreement”), between the Issuer and the Representative, on behalf of the Initial Purchasers, which provides for the sale by the Issuer to the Initial Purchasers of an aggregate of $1,050,000,000 principal amount of the Issuer’s 4.375% Senior Notes due 2019 (the “2019 Notes”) and an aggregate of $750,000,000 principal amount of the Issuer’s 4.875% Senior Notes due 2021 (the “2021 Notes”). As used herein, “Securities” shall mean the 2019 Notes and the 2021 Notes, as individual series of notes and not collectively. In order to induce the Initial Purchasers to enter into the Purchase Agreement and for good and valuable consideration to the Holders of the Securities, the Issuer has agreed to provide to the Initial Purchasers and their direct and indirect transferees the registration rights set forth in this Agreement. The execution and delivery of this Agreement is a condition to the closin
